Inflammatory Bowel Disease (IBD) Therapeutics Market Share

Market Share of Inflammatory Bowel Disease (IBD) Therapeutics Industry

The inflammatory bowel disease (IBD) therapeutics market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies that are currently dominating the market are Bristol-Myers Squibb Company, AbbVie Inc., Allergan Therapeutics LLC, Bausch Health Companies Inc. (Salix Pharmaceuticals), Rare Disease Therapeutics Inc., Johnson & Johnson Services Inc., Janssen Biotech, Inc., UCB Inc., and others.

Inflammatory Bowel Disease (IBD) Therapeutics Market Leaders

1. Bristol-Myers Squibb Company

2. AbbVie Inc.

3. Takeda Pharmaceutical Company Limited

4. Johnson & Johnson Services Inc. (Janssen Biotech, Inc.)

5. Bausch Health Companies Inc. (Salix Pharmaceuticals)

*Disclaimer: Major Players sorted in no particular order